Reports on the Food and Drug Administration's (FDA) approval of a class of non-nucleoside reverse transcriptase inhibitors called Viramune or nevirapine for adult use in combination with other AIDS drugs. Treatment of adult HIV patients whose health has deteriorated; Drug's interference with HIV replication; Side effects; Studies conducted by manufacturer Boehringer Ingleheim Pharmaceuticals Inc.
Processing Request
No Comments.